Seeking Alpha

Cornerstone Therapeutics EPS of $0.33, beats on revenues

  • Cornerstone Therapeutics (CRTX): Q2 EPS of $0.33.
  • Revenue of $40.4M beats by $4.61M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)